Mulmit

Ovid Therapeutics Inc.Ovid Therapeutics Inc.

OVID Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-317,252,000-42,439,000-17,400,000—
2024-12-31566,000-61,885,000-26,400,000—
2023-12-31392,000-59,281,000-52,300,000-0.74
2022-12-311,502,748-55,548,161-54,169,029-0.77
2021-12-31208,382,779124,209,092122,834,5841.76

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-06Carter Charles RossChief Financial Officer50,000
2026-06-15Greka Anna130,000
2026-04-07Fitzgerald Kevin Joseph17,578
2026-04-07Friedman Bart8,789
2026-04-07PAPADOPOULOS STELIOS17,578
2026-03-23LEVIN JEREMY MExecutive Chairman47,333
2026-03-23LEVIN JEREMY MExecutive Chairman47,333
2026-02-26ALEXANDER MARGARET A.President and CEO1,435,000
2026-02-26Fitzgerald Kevin Joseph65,000
2026-02-26Bernstein Karen65,000
2026-02-26Friedman Bart65,000
2026-02-26DUNCAN BARBARA GAYLE65,000

8-K events

FiledItems
2026-08-13Financial statements and exhibits
2026-07-08Officer or director change
2026-06-11Submission of matters to a vote
2026-06-03Officer or director change
2026-05-12Financial statements and exhibits
2026-04-20Other events
2026-03-18Entry into a material agreement · Results of operations · Unregistered sales of equity securities · Financial statements and exhibits
2025-12-18Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard